MNMD Q2 2022 Earnings — Mind Medicine (MindMed) Inc. Revenue & Financial Results | Market Cap Arena

MNMDMind Medicine (MindMed) Inc.

$1B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$17M

Net Income

-$17M

EPS (Diluted)

$-0.60

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$134M

Total Liabilities

$10M

Stockholders' Equity

$125M

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$17M	-$45M	+62.5%
Net Income	-$17M	-$45M	+62.5%